Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Seidman

Showing results (321-330 of 386) with videos related to

Pageof 39
Sort By:
The Breast Journal|May 22, 2012
Limited overall survival in patients with brain metastases from triple negative breast cancerPatrick G Morris, Conleth G Murphy, Divya Mallam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2019
Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System MetastasesAki Morikawa, Elisa de Stanchina, Elena Pentsova, et al.
Breast Cancer Research and Treatment|April 2, 2005
A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancerShanu Modi, Andrew D Seidman, Maura Dickler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2007
Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patientsGary Deng, Andrew Vickers, Simon Yeung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancerA D Seidman, C A Hudis, J Albanell, et al.
Seminars in Oncology|August 1, 1993
Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancerA D Seidman, L Norton, B S Reichman, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1993
Taxol plus recombinant human granulocyte-colony stimulating factor as initial and as salvage chemotherapy for metastatic breast cancer: a preliminary reportA D Seidman, B S Reichman, J P Crown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline responseA D Seidman, B S Reichman, J P Crown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2011
Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarraysE Brogi, C G Murphy, M L Johnson, et al.
Oncology|October 1, 1994
Taxol (paclitaxel) plus recombinant human granulocyte colony-stimulating factor in the treatment of metastatic breast cancerA D Seidman, L Norton, B S Reichman, et al.
Pageof 39

Showing results (321-330 of 386) with videos related to

Sort By:
Pageof 39
The Breast Journal|May 22, 2012
Limited overall survival in patients with brain metastases from triple negative breast cancerPatrick G Morris, Conleth G Murphy, Divya Mallam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2019
Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System MetastasesAki Morikawa, Elisa de Stanchina, Elena Pentsova, et al.
Breast Cancer Research and Treatment|April 2, 2005
A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancerShanu Modi, Andrew D Seidman, Maura Dickler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2007
Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patientsGary Deng, Andrew Vickers, Simon Yeung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancerA D Seidman, C A Hudis, J Albanell, et al.
Seminars in Oncology|August 1, 1993
Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancerA D Seidman, L Norton, B S Reichman, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1993
Taxol plus recombinant human granulocyte-colony stimulating factor as initial and as salvage chemotherapy for metastatic breast cancer: a preliminary reportA D Seidman, B S Reichman, J P Crown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline responseA D Seidman, B S Reichman, J P Crown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2011
Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarraysE Brogi, C G Murphy, M L Johnson, et al.
Oncology|October 1, 1994
Taxol (paclitaxel) plus recombinant human granulocyte colony-stimulating factor in the treatment of metastatic breast cancerA D Seidman, L Norton, B S Reichman, et al.
Pageof 39